Nikhil Lalwani, President and CEO of ANI stated, "ILUVIEN's expanded label and the strengthening of our partnership with long ...
20h
ILUVIEN now approved for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye (NIU-PS) in addition to diabetic macular edema (DME)ANI plans to begin marketing ILU ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback